SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Insmed Inc – ‘8-K’ for 1/4/01

On:  Thursday, 1/4/01, at 5:16pm ET   ·   For:  1/4/01   ·   Accession #:  916641-1-8   ·   File #:  0-30739

Previous ‘8-K’:  ‘8-K’ on 12/1/00 for 11/28/00   ·   Next:  ‘8-K’ on 2/28/01 for 2/27/01   ·   Latest:  ‘8-K’ on 3/11/24 for 3/8/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/04/01  Insmed Inc                        8-K:5,7     1/04/01    2:9K                                     Donnelly Financial/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         4     11K 
 2: EX-99       Press Release                                          2     11K 


8-K   —   Current Report
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
2Item 5. Other Events
"Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
8-K1st Page of 4TOCTopPreviousNextBottomJust 1st
 

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 4, 2001 INSMED INCORPORATED (Exact name of registrant as specified in its charter) [Enlarge/Download Table] VIRGINIA 0-30739 54-1972729 ------------------------------------------------------------------------------------------------------------------- (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation) Identification No.) 800 East Leigh Street, Richmond, VA 23219 (Address of principal executive offices and zip code) Registrant's telephone number, including area code: (804) 828-6893
8-K2nd Page of 4TOC1stPreviousNextBottomJust 2nd
ITEM 5. OTHER EVENTS On January 4, 2001, Insmed Incorporated issued a press release announcing the results following a full analysis of its recently completed clinical trial of Type 2 diabetes patients treated with INS-1 in combination with sulfonylureas. Insmed also announced in the press release that Insmed's management team will host a conference call on Friday, January 5 at 8:00 a.m. EST to discuss these results. The dial-in number is 800-289-0437 (domestic) or 913-981-5508 (international). The reference code is 509579. A replay of the call will be available from 11:00 a.m. EST, Friday, January 5 through 11:00 a.m. EST, Friday, January 12, 2001. The replay dial-in number is 888-203-1112 (domestic) or 719-457-0820 (international). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The press release was also posted on Insmed's website on January 4, 2001. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibit 99.1 Press Release dated January 4, 2001.
8-K3rd Page of 4TOC1stPreviousNextBottomJust 3rd
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSMED INCORPORATED Date: January 4, 2001 By: /s/ Michael D. Baer --------------------- Michael D. Baer Chief Financial Officer
8-KLast Page of 4TOC1stPreviousNextBottomJust 4th
INSMED INCORPORATED INDEX TO EXHIBITS Exhibit Number 99.1 Press Release dated January 4, 2001.

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘8-K’ Filing    Date First  Last      Other Filings
1/12/012None on these Dates
Filed on / For Period End:1/4/0114
 List all Filings 
Top
Filing Submission 0000916641-01-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 5:51:34.5pm ET